Tenecteplase versus alteplase in elderly stroke: a post hoc analysis of the AcT trial
{{output}}
Background: Stroke rates rise steeply with age but data on tenecteplase in patients ≥80 years remain limited. This post-hoc analysis of the AcT trial compared tenecteplase with alteplase in this population. ... ...
